MedPath

BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: BAY987517
First Posted Date
2016-07-22
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
15
Registration Number
NCT02842268

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

Completed
Conditions
Angiography
Multidetector Computed Tomography
Interventions
First Posted Date
2016-07-21
Last Posted Date
2018-10-02
Lead Sponsor
Bayer
Target Recruit Count
1214
Registration Number
NCT02840903

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

Completed
Conditions
Hemophilia A, Congenital
Interventions
Biological: Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973
First Posted Date
2016-07-13
Last Posted Date
2023-11-07
Lead Sponsor
Bayer
Target Recruit Count
313
Registration Number
NCT02830477
Locations
🇺🇸

East Carolina University - Brody School of Medicine, Greenville, North Carolina, United States

🇺🇸

Hemophilia Center of Western New York, Buffalo, New York, United States

🇺🇸

Children's Rehabilitation Services/ University of South Alabama, Mobile, Alabama, United States

and more 10 locations

Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: BAY987517
Drug: Sunscreen Lotion (RB# T78-190B)
First Posted Date
2016-07-13
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
98
Registration Number
NCT02831478

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Completed
Conditions
Hypertension, Pulmonary
Interventions
First Posted Date
2016-07-07
Last Posted Date
2024-08-19
Lead Sponsor
Bayer
Target Recruit Count
282
Registration Number
NCT02825160
Locations
🇯🇵

Many Locations, Multiple Locations, Japan

Sun Protection Factor Assay (SPF Assay 18677)

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY 987517)
First Posted Date
2016-07-07
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02825017

Sun Protection Factor Assay (SPF Assay 18676)

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY 987516)
First Posted Date
2016-07-07
Last Posted Date
2018-12-13
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02825030

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Completed
Conditions
Hypertension, Pulmonary
Interventions
Drug: Iloprost,(Ventavis, BAYQ6256)
Device: I-Neb AAD system
First Posted Date
2016-07-07
Last Posted Date
2017-03-15
Lead Sponsor
Bayer
Target Recruit Count
64
Registration Number
NCT02826252

18349-Human Photoallergy Test

Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Other: Sunscreen Lotion , BAY 987521
Other: Untreated skin
First Posted Date
2016-07-06
Last Posted Date
2016-07-06
Lead Sponsor
Bayer
Target Recruit Count
60
Registration Number
NCT02823496

18348-Human Phototoxicity Test

Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Other: Sunscreen Lotion (BAY987521)
Other: Untreated Skin
First Posted Date
2016-07-06
Last Posted Date
2016-07-06
Lead Sponsor
Bayer
Target Recruit Count
35
Registration Number
NCT02823483
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy